Livagen
Liver bioregulator peptide from the Khavinson series. Short peptide (2-4 amino acids) that targets specific tissue for gene expression regulation and organ health optimization.
Beginner Basics
Plain-English guide to Livagen
What it does
Livagen is a short chain of amino acids that researchers study for supporting liver health and function. It's typically used in research to help the liver clean toxins from the body, repair damaged liver cells, and boost the liver's natural protective systems.
Typical dose
Researchers commonly use 10-20 micrograms once or twice daily, either as a small injection under the skin or under the tongue. Most start with 10 micrograms and may increase to 20 micrograms split into two doses.
When to inject
Typically given in the morning and/or evening. Timing doesn't appear to be critical, so inject based on what fits your routine.
Storage
Keep the dry powder in a freezer at -20°C until you mix it. After mixing with liquid, store it in a regular refrigerator between 2-8°C and keep it away from direct light.
First-timer tip
Start with the lowest dose (10 mcg once daily) for at least a week to see how your body responds before increasing to twice daily or higher doses.
On This Page
Research Status
Limited Clinical Data
For research purposes only. Not approved for human use. Not medical advice.
Research Areas
Side Effects
Mild redness, swelling, or itching at the injection site may occur, particularly with repeated injections at the same site. Rotate injection sites to minimize this risk. Reactions typically resolve within 1-2 hours.
Localized urticaria or rash at the injection site may occur in individuals with sensitivity to bovine peptides or excipients. Discontinue use and consult a healthcare provider if this occurs.
Anaphylaxis or severe allergic reaction is extremely rare but possible. Symptoms include difficulty breathing, facial swelling, or severe rash. Seek immediate medical attention if these occur. Individuals with known bovine protein allergies should avoid this peptide.
Mild nausea, stomach discomfort, or changes in appetite may occur with sublingual administration. Taking the peptide with food or switching to subcutaneous injection may reduce symptoms.
Mild headache may occur in the first few days of use, particularly with 2x daily dosing. This typically resolves as the body adjusts. Ensure adequate hydration.
Transient dizziness may occur shortly after injection. Sit or lie down if this occurs. Ensure you are well-hydrated and have eaten before injection.
Repeated injections at the same site may cause localized fat loss (lipoatrophy) or fat thickening (lipohypertrophy). Strict site rotation (at least 1 inch between injection points) prevents this complication. If lipodystrophy develops, discontinue injections at that site for 4-6 weeks.
Dosing Reference
| Parameter | Value |
|---|---|
| Dose range | 10-20 mcg |
Frequency, timing and route - members only | |
Research disclaimer
Figures drawn from published research literature and community logs. Not clinical recommendations. Consult a qualified professional. Research use only.
Reconstitution Guide
Do not use saline or bacteriostatic saline, use only bacteriostatic water for reconstitution
Do not shake the vial vigorously; gentle swirling prevents peptide degradation
Discard immediately if the solution appears cloudy, discolored, or contains visible particles
Use within 30 days of reconstitution when stored at 2-8°C
Do not freeze the reconstituted solution; freezing may denature the peptide
Use the PeptideVolt reconstitution calculator for your exact concentration
Molecular and Pharmacological Data
Livagen is a short peptide bioregulator derived from bovine liver tissue that is believed to act as a tissue-specific signaling molecule. It may regulate gene expression in hepatocytes through receptor-mediated pathways, promoting the synthesis of liver-specific proteins, enhancing detoxification enzyme activity, and supporting cellular regeneration and antioxidant defense mechanisms. The peptide is thought to work through epigenetic and post-transcriptional regulation rather than direct enzymatic activity.
Track your Livagen research
Free account. No credit card required.
Recent Research
EPIGENETIC MODIFICATION UNDER THE INFLUENCE OF PEPTIDE BIOREGULATORS ON THE "OLD" CHROMATIN.
[The influence of polypeptide liver complex and tetrapeptide KEDA on organism physiological function in norm and age-related pathology.].
[EVALUATION OF GENOMIC PARAMETERS IN DUCTAL BREAST CANCER PATIENTS AND THE ABILITY OF IT'S CORRECTION].
Source: PubMed / NCBI. Updated daily. Articles are listed for research reference only.
Browse the Research Library
40+ peptide profiles with mechanism summaries, dosing data, and reconstitution guides.
View all peptidesResearch Use Only. All content on this page is provided for informational and educational purposes related to scientific research. Livagen is not approved for human use by the FDA or any equivalent regulatory body. This is not medical advice. Do not use any substance discussed here for therapeutic, diagnostic, or preventative purposes. Consult a qualified healthcare professional before making any health-related decisions. The Peptide Volt does not endorse the use of any research chemicals. 18+ only.